Alignment Healthcare Q2 2024 GAAP EPS $(0.13) Beats $(0.14) Estimate, Sales $681.286M Beat $637.649M Estimate
Portfolio Pulse from Benzinga Newsdesk
Alignment Healthcare (NASDAQ:ALHC) reported Q2 2024 GAAP EPS of $(0.13), beating the estimate of $(0.14). Sales were $681.286M, surpassing the $637.649M estimate and marking a 47.34% increase from the same period last year.
August 01, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alignment Healthcare reported better-than-expected Q2 2024 earnings and revenue, with a significant year-over-year sales increase.
The company's better-than-expected earnings and revenue, along with a significant year-over-year sales increase, are likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100